Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors
Public ClinicalTrials.gov record NCT02611544. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors: A Randomized Clinical Pilot Trial
Study identification
- NCT ID
- NCT02611544
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Indiana University
- Other
- Enrollment
- 91 participants
Conditions and interventions
Conditions
- Breast Neoplasms
- Breast Cancer
- Breast Carcinoma
- Malignant Neoplasm of Breast
- Cancer of Breast
- Mammary Neoplasm, Human
- Human Mammary Carcinoma
- Malignant Tumor of Breast
- Mammary Cancer
- Mammary Carcinoma
- Anxiety
- Fear
- Neoplasm Remission, Spontaneous
- Spontaneous Neoplasm Regression
- Regression, Spontaneous Neoplasm
- Remission, Spontaneous Neoplasm
- Spontaneous Neoplasm Remission
Interventions
- Acceptance and Commitment Therapy Behavioral
- Survivorship Education Behavioral
- Enhanced Usual Care Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2015
- Primary completion
- Nov 30, 2016
- Completion
- Nov 30, 2016
- Last update posted
- Jun 25, 2019
2015 – 2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Indiana University | Indianapolis | Indiana | 46202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02611544, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 25, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02611544 live on ClinicalTrials.gov.